News
Dr Smith invited to speak at Parkinson’s UK events
Dr Stephen Smith will be a speaker at the sell-out Parkinson’s UK 2017 Research Support Network Conference in Birmingham in October. The conference provides people affected by Parkinson’s the ideal...
Dr Smith invited to speak at Parkinson’s UK events
Dr Stephen Smith will be a speaker at the sell-out Parkinson’s UK 2017 Research Support Network Conference in Birmingham in October. The conference provides people affected by Parkinson’s the ideal...
‘Lifesaver’ Smith recognised for Parkinson’s re...
Professor Stephen Smith has been hailed a ‘national lifesaver’ in recognition of his research into the diagnosis and treatment of Parkinson’s. Smith – ClearSky’s co-founder and director – and his...
‘Lifesaver’ Smith recognised for Parkinson’s re...
Professor Stephen Smith has been hailed a ‘national lifesaver’ in recognition of his research into the diagnosis and treatment of Parkinson’s. Smith – ClearSky’s co-founder and director – and his...
SCOR Innovation Podcast: Interview with Profess...
ClearSky’s co-founder Professor Stephen Smith discusses disruptive healthcare technologies in neurodegenerative diseases in the latest SCOR Innovation Podcast. The SCOR Innovation Podcast channel sheds light on evolving consumer needs in...
SCOR Innovation Podcast: Interview with Profess...
ClearSky’s co-founder Professor Stephen Smith discusses disruptive healthcare technologies in neurodegenerative diseases in the latest SCOR Innovation Podcast. The SCOR Innovation Podcast channel sheds light on evolving consumer needs in...
Global recognition for ClearSky Medical Diagnos...
ClearSky Medical Diagnostics is recognised as an ‘up and coming’ company tackling neurodegenerative disease through technology. Data science company StartUs Insights, which identifies startups, disruptive technologies and new business models...
Global recognition for ClearSky Medical Diagnos...
ClearSky Medical Diagnostics is recognised as an ‘up and coming’ company tackling neurodegenerative disease through technology. Data science company StartUs Insights, which identifies startups, disruptive technologies and new business models...
LID-Monitor to also ‘manage bradykinesia’ // Ch...
We have launched a new study in China to establish introducing bradykinesia as a feature being measured by LID-Monitor. Parkinson’s is the second most common neurodegenerative disorder and is characterised...
LID-Monitor to also ‘manage bradykinesia’ // Ch...
We have launched a new study in China to establish introducing bradykinesia as a feature being measured by LID-Monitor. Parkinson’s is the second most common neurodegenerative disorder and is characterised...
Featured Blogs
-
Finger tapping test and Parkinson’s
Learn MoreDiagnosis of Parkinson’s can be difficult to confirm by conventional assessments – relying on the judgement of a clinician observing and rating a patient’s movements, or costly brain scans.
-
Finger Tapping May Differentiate Parkinson’s From Essential Tremor
Learn MoreEssential tremor (ET) is a neurological disorder that causes involuntary and rhythmic shaking.
-
Parkinson’s and statins: PD-Monitor in clinical study
Learn MoreClearSky’s PD-Monitor has been used in a major UK study to investigate whether statins are effective in slowing the progress of Parkinson’s.
Other Products
-
Living with Parkinson’s: Using the LID-Monitor
Learn MoreLevodopa is one of the main medications used to treat symptoms of Parkinson’s. As Parkinson’s progresses the doses of levodopa needed to maintain control over symptoms increases.
-
What is levodopa-induced dyskinesia?
Learn MoreLevodopa is the most effective and commonly used drug for treating Parkinson’s. It is a chemical building-block that your body converts into dopamine.
-
Partners Wanted to Accelerate Development of Mild Cognitive Impairment Diagnostic Device
Learn MoreClearSky Medical Diagnostics has developed an intelligent medical device that can objectively diagnose mild cognitive impairment (MCI), a condition often suggested as an early stage of dementia.
-
How drawing on an iPad could lead to Alzheimer’s diagnosis
Learn MoreComplex figure tests are widely used neuropsychological tests where participants are asked to reproduce a complicated line drawing, first by copying it freehand and then drawing it from memory.
Company News
-
LID-Monitor to also ‘manage bradykinesia’ // China study
Learn MorePair text with an image to focus on your chosen product, collection, or blog post. Add details on availability, style, or even provide a review.
-
Global recognition for ClearSky Medical Diagnostics
Learn MoreClearSky Medical Diagnostics is recognised as an ‘up and coming’ company tackling neurodegenerative disease through technology.
-
SCOR Innovation Podcast: Interview with Professor Smith
Learn MoreClearSky’s co-founder Professor Stephen Smith discusses disruptive healthcare technologies in neurodegenerative diseases in the latest SCOR Innovation Podcast.
-
‘Lifesaver’ Smith recognised for Parkinson’s research
Learn MoreProfessor Stephen Smith has been hailed a ‘national lifesaver’ in recognition of his research into the diagnosis and treatment of Parkinson’s.
-
https://www.clearskymd.com/smith-invited-parkinsons-uk-events/
Learn MoreDr Stephen Smith will be a speaker at the sell-out Parkinson’s UK 2017 Research Support Network Conference in Birmingham in October.